Synergistic combination of n-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 1, 2004, Pages 99-102

  Ghezzi, Pietro ^a   Ungheri, D ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Sandoz PF   (Italy)

Author keywords

Influenza; N acetylcysteine; Ribavirin

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ANTIVIRUS AGENT; RIBAVIRIN;

ADOLESCENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; DRUG POTENTIATION; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A APR 8; LETHALITY; LUNG INJURY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURVIVAL; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; MORTALITY; ORTHOMYXOVIRUS INFECTION; SURVIVAL RATE;

ACETYLCYSTEINE; ANIMALS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; INFLUENZA A VIRUS; MALE; MICE; ORTHOMYXOVIRIDAE INFECTIONS; RIBAVIRIN; SURVIVAL RATE;

EID: 5444230301     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700114     Document Type: Article

References (21)

1. Kennet, T., E. Peterhans and R. Stocker. 1992. Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus. J. Gen. Virol. 73:39.
2. Akaike, T., M. Ando, T. Oda, T. Doi, S. Ijiri, S. Araki and H. Maeda. 1990. Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J. Clin. Invest. 85:739.
3. Ungheri, D., C. Pinasi, G. Sanson, A. Bertani, G. Schioppacassi, R. Delgado, M. Sironi and P. Ghezzi. 2000. Protective effect of N-acetylcysteine in a model of influenza infection in mice. Int. J. Immunopathol. Pharmacol. 13:123.
4. Nakamura, H., S. Tamura, I. Watanabe, T. Iwasaki and J. Yodoi. 2002. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol. Lett. 82:165.
5. Kaul, P., M. C. Biagioli, I. Singh and R. B. Turner. 2000. Rhinovirus-induced oxidative stress and interleukin-8 elaboration involves p47-phox but is independent of attachment to intercellular adhesion molecule-1 and viral replication. J. Infect. Dis. 181:1885.
6. Biagioli, M. C., P. Kaul, I. Singh and R. B. Turner. 1999. The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells. Free Radic. Biol. Med. 26:454.
7. Roederer, M., F. J. T. Staal, P. A. Raju, S. W. Ela and L. A. Herzenberg. 1990. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetylcysteine. Proc. Natl. Acad. Sci. 87:4884.
8. Herzenberg, L. A., S. C. De Rosa, J. G. Dubs, M. Roederer, M. T. Anderson, S. W. Ela and S. C. Deresinski. 1997. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. USA 94:1967.
9. Folkerts, G. and F. P. Nijkamp. 1995. Virus-induced airway hyperresponsiveness. Role of inflammatory cells and mediators. Am. J. Respir. Crit. Care Med. 151:1666.
10. Geiss, G. K., M. C. An, R. E. Bumgarner, E. Hammersmark, D. Cunningham and M. G. Katze. 2001. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J. Virol. 75:4321.
11. Peristeris, P., B. D. Clark, S. Gatti, R. Faggioni, A. Mantovani, M. Mengozzi, S. F. Orencole, M. Sironi and P. Ghezzi. 1992. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell. Immunol. 140:390.
12. DeFlora, S., C. Grassi and L. Carati. 1997. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur. Respir. J. 10:1535.
13. Staal, F. J., M. T. Anderson, G. E. Staal, L. A. Herzenberg and C. Gitler. 1994. Redox regulation of signal transduction: tyrosinephosphorylation and calcium influx. Proc. Natl. Acad. Sci. 91:3619.
14. Schreck, R., P. Rieber and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247.
15. Villa, P., A. Saccani, A. Sica and P. Ghezzi. 2002. Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. J. Infect. Dis. 185:1115.
16. Kotake, Y., D. R. Moore, A. Vasquez-Waiden, T. Tabatabaie and H. Sang. 2003. Antioxidant amplifies antibiotic protection in the cecal ligation and puncture model of microbial sepsis through interleukin-10 production. Shock 19:252.
17. Van Der Sluijs, K. F., L. Van Elden, M. Nijhuis, R. Schuurman, H. M. Jansen, K. Takeda, S. Akira, R. Lutter and T. Van Der Poll. 2002. IL-18 Gene Deficient Mice Demonstrate an Accelerated Viral Clearance and Reduced Lung Inflammation after Influenza Infection. In 42nd annual ICAAC. San Diego, p. 1.
18. Breitkreutz, R., N. Pittack, C. T. Nebe, D. Schuster, J. Brust, M. Beichert, V. Hack, V. Daniel, L. Edler and W. Droge. 2000. Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials. J. Mol. Med. 78:55.
19. Grant, P. R., A. Black, N. Garcia, J. Prieto and J. A. Garson. 2000. Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study. J Med. Virol. 61:439.
20. Perrella O., M. Perrella, V. Cusumano, U. Ibello, C. Sbreglia, R. De Sena and A. Perrella. 2002. Interleukin-10 and transforming growth factor beta 1 in hepatic fibrosis. Int. J. Immunopathol. Pharmacol. 15:243.
21. De Franceschi, L., G. Fattovich, F. Turrini, K. Ayi, C. Brugnara, F. Manzato, F. Noventa, A. M. Stanzial, P. Solero and R. Corrocher. 2000. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 31:997.